Translation Excellence provides GxP-compliant language solutions for the world’s leading Pharma, Biotech, and MedTech innovators. We help you navigate the complexities of FDA, EMA, and NMPA requirements with audit-ready precision.
From Informed Consent Forms (ICF) to Clinical Study Reports (CSR), we ensure culturally adapted, patient-centric communication that drives enrollment and protects data integrity.
High-stakes translation for eCTD submissions, Labelling, and Summary of Product Characteristics (SmPC) to ensure seamless approval across global markets.
Rapid-response translation for Adverse Event (AE) reporting and post-market surveillance to maintain global compliance and patient safety.
ISO 13485-aligned translation for IFUs (Instructions for Use), UI/UX, and technical manuals for Class I, II, and III medical devices.
Your science is complex. Your translators should be too. We don’t use generalists; your content is handled by MDs, PhDs, and specialized linguists with deep expertise in Oncology, Neurology, Immunology, and Rare Disease.
A strategic guide for Regulatory Affairs directors to ensure linguistic readiness for FDA, EMA, and NMPA submissions. Identify gaps in your documentation before they become findings.